EISAI-E7080-J081-105



A Phase 1 Study of E7080 in Subjects With Solid Tumor
lenvatinib
E7080-J081-105
NCT01268293
Solid Tumors
Phase 1
 
Can only share aggregated data due to risk of re-identification. Note: Japan is the only country participating in this study.
September 2015